Announcement on the allocation of equity and adjustment of convertible debt-to-share prices in 2022
Announcement on the results of the resale of “Borui Convertible Bonds”
Third indicative announcement on optional resale of “Borui Convertible Bonds”
Second indicative announcement on optional resale of “Borui Convertible Bonds”
First indicative announcement on optional resale of “Borui Convertible Bonds”
Announcement on optional resale of “Borui Convertible Bonds”
Notice on holding the first “Borui Convertible Bonds” bond holders' meeting in 2023
Indicative announcement on “Borui Convertible Bonds” expected to meet the conversion price correction conditions
Announcement on the 2022 interest payment of “Borui Convertible Bonds”
Borui Pharmaceuticals: Announcement on the reduction of holders' holdings of convertible corporate bonds
Borui Pharmaceuticals: Announcement on the reduction of holders' holdings of convertible corporate bonds
Borui Pharmaceutical: Announcement on “Borui Convertible Bonds” to track credit rating results
Borui Pharmaceutical: 2021 Annual Equity Distribution Implementation Notice
Announcement on the allocation of equity and adjustment of convertible debt-to-share prices in 2021
2021 Annual Equity Distribution Implementation Notice
Borui Pharmaceutical: 2021 Annual Profit Distribution Plan Announcement
Borui Pharmaceuticals: Online Roadshow Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets
Announcement on the listing transaction of Borui Biomedical (Suzhou) Co., Ltd.'s RMB common stock stock on the Science and Technology Innovation Board
No Data